Efficacy evaluation of denosumab in the treatment of patients with postmenopausal osteoporosis at high risk of fracture

Efficacy evaluation of denosumab in the treatment of patients with postmenopausal osteoporosis at high risk of fracture

ObjectiveTo explore the difference of efficacy and safety between denosumab and zoledronic acid in the treatment of patients with postmenopausal osteoporosis (PMOP), and to optimize the medication regimen for PMOP patients. MethodsA total of 123 PMOP patients with high risk of fracture at the Second...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing ZHOU, Xingyun HOU, Tingting LIU, Jiaoyang ZHENG
Format: Article
Language:English
Published: Shanghai Chinese Clinical Medicine Press Co., Ltd. 2025-02-01
Series:Zhongguo Linchuang Yixue
Subjects:
high risk of fracture
postmenopausal osteoporosis
denosumab
zoledronic acid
Online Access:https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20241118
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items